Objective: To measure insulin and glucagon concentrations in amniotic fluid
(AF) collected near term in basal conditions and after an arginine test in
diabetic, rhesus-isoimmunized, and control pregnant women.
Methods: At baseline, AF was collected from 44 diabetic, 32 rhesus-isoimmun
ized, and 27 control pregnant women in late pregnancy. Fifty-two diabetic,
six rhesus-isoimmunized, and nine control pregnant women had amniocentesis
2 hours after arginine infusion (30 g intravenous/30 minutes) at 33-36 week
s.
Results: Baseline AF glucose concentrations were significantly greater in d
iabetic women than the other conditions, and they related to the gestationa
l age in the women with hemolytic disease of the newborn. Insulin and gluca
gon AF content of isoimmunized pregnancies overlapped controls, whereas ins
ulin and insulin/glucagon molar ratios were significantly higher, and gluca
gon values lower, in diabetic pregnancies compared with isoimmunized and co
ntrol pregnancies. In isoimmunized pregnancies, the AF concentrations of gl
ucose, insulin, and glucagon were correlated with gestational age (less tha
n 34, 34 weeks or more). The samples collected after arginine infusion, com
pared with those collected at baseline, showed significantly greater insuli
n and insulin/glucagon molar ratio values in diabetic (28 +/- 5 versus 11 /- 1 mu U/mL, P = .001; 29.4 +/- 1.7 versus 12.0 +/- 2.8, P = .001) and in
Rh pregnant women (18 +/- 6 versus 7.7 +/- 0.7 mu U/mL, P = .001; 30 +/- 9
versus 3.4 +/- 0.4 I/G, P = .001), whereas no significant difference was ob
served in the controls.
Conclusion: Basal islet hormone concentrations in AF axe modified by matern
al diabetes and further influenced by arginine administration. Arginine pro
duces an AF response that is similar in pregnancies complicated by diabetes
mellitus and rhesus-isoimmunization, despite different (hyperglycemia and
euglycemia) maternal blood glucose levels. (C) 2000 by The American College
of Obstetricians and Gynecologists.